Type I Diabetes and Non-surgical Periodontal Treatment
- Conditions
- PeriodontitisPeriodontal DiseasesDiabetesType 1 DiabetesDiabetes MellitusDiabetes Mellitus, Type 1
- Interventions
- Procedure: Non-surgical periodontal therapy
- Registration Number
- NCT05569525
- Lead Sponsor
- University of Florence
- Brief Summary
Current evidence suggests a bidirectional association between periodontitis and diabetes. Periodontal therapy improves short term HbA1c levels and is safe to perform. Most studies are focused on type 2 Diabetes. Literature about the correlation between periodontitis and type 1 diabetes is scarce, since no randomized clinical trials have been performed.
The objective of the present clinical investigation is to evaluate the effects of nonsurgical treatment of periodontal disease on glycemic variability in patients with type 1 diabetes (T1DM). The hypothesis is that nonsurgical periodontal therapy affects glycemic variability in terms of time spent in hyperglycemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Diagnosis of Type 1 diabetes
- Patients under treatment in the department of Diabetology of AOU Careggi having a microinfusor for continuous subcutaneous insulin infusion (CSII) and a Flash Glucose Monitoring (FGM) device
- Diagnosis of periodontitis (all stages and grades)
- Contraindications for non-surgical periodontal therapy
- Pregnancy
- History of other systemic disease (cancer, HIV, bone metabolic dysease, Head and Neck Radiotherapy, Immunosuppressive/modulating therapy)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Non-surgical periodontal therapy Patients receiving non-surgical periodontal treatment 6 months after the enrollment. Test Non-surgical periodontal therapy Patients receiving non-surgical periodontal treatment within 1 week from enrollment.
- Primary Outcome Measures
Name Time Method Glycated hemoglobin (HbA1c) 6 months after the non-surgical periodontal treatment Glycated hemoglobin (HbA1c) to evaluate glycemic variability measured as a percentage (%).
- Secondary Outcome Measures
Name Time Method Standard Deviation (SD) of glycaemia 6 months after the non-surgical periodontal treatment Standard Deviation: the spread of glucose readings around the average (mg/dl)
Glucose coefficient of variability (CV) 6 months after the non-surgical periodontal treatment CV is a calculation: dividing the SD by the mean glucose and multiplying by 100 to get a percentage (%).
Trial Locations
- Locations (1)
Università degli Studi di Firenze
🇮🇹Firenze, FI, Italy